Celularity (CELU) Common Equity (2020 - 2025)
Celularity (CELU) has disclosed Common Equity for 6 consecutive years, with -$38.1 million as the latest value for Q4 2025.
- For Q4 2025, Common Equity fell 530.71% year-over-year to -$38.1 million; the TTM value through Dec 2025 reached -$38.1 million, down 530.71%, while the annual FY2025 figure was -$38.1 million, 530.71% down from the prior year.
- Common Equity hit -$38.1 million in Q4 2025 for Celularity, down from -$20.1 million in the prior quarter.
- Across five years, Common Equity topped out at $198.9 million in Q4 2022 and bottomed at -$648.2 million in Q2 2021.
- Average Common Equity over 5 years is -$6.0 million, with a median of $30.7 million recorded in 2023.
- Year-over-year, Common Equity surged 123.16% in 2022 and then tumbled 530.71% in 2025.
- Celularity's Common Equity stood at $99.4 million in 2021, then skyrocketed by 100.07% to $198.9 million in 2022, then plummeted by 79.41% to $41.0 million in 2023, then plummeted by 78.43% to $8.8 million in 2024, then crashed by 530.71% to -$38.1 million in 2025.
- According to Business Quant data, Common Equity over the past three periods came in at -$38.1 million, -$20.1 million, and -$25.5 million for Q4 2025, Q3 2025, and Q2 2025 respectively.